This inventor holds 1 USPTO granted patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Takahiro Ol: Innovator in Diabetes Treatment
Introduction
Takahiro Ol is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating diabetes. His innovative work has led to the creation of a unique patent that addresses critical health issues.
Latest Patents
Takahiro Ol holds a patent for 1-thio-D-glucitol derivatives. This invention provides a 1-thio-D-glucitol compound that inhibits the activity of SGLT2, which is crucial for managing diabetes. The patent includes pharmaceutically acceptable salts of the compound, hydrates, and a pharmaceutical formulation that utilizes this compound as an active ingredient. This formulation is particularly aimed at preventing or treating diabetes and its related complications. Additionally, the patent outlines a method for producing the 1-thio-D-glucitol compound and its intermediates.
Career Highlights
Takahiro Ol is associated with Taisho Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in diabetes treatment. His work has not only contributed to the scientific community but has also had a positive impact on patient care.
Collaborations
Takahiro has collaborated with notable colleagues such as Hiroyuki Kakinuma and Yuko Hashimoto. Their combined expertise has fostered an environment of innovation and progress within their field.
Conclusion
Takahiro Ol's contributions to diabetes treatment through his patented inventions highlight his role as a key innovator in the pharmaceutical industry. His work continues to pave the way for advancements in medical science and patient care.